A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response ...
The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the Division of Intelligent Robot at DGIST (under President Kunwoo Lee) has ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...
During early development, tissues and organs begin to form through the shifting, splitting, and growing of many thousands of cells. A team of researchers headed by MIT engineers has now developed a ...
The scSurv is a method that deconvolutes bulk RNA-seq data into individual single cells using scRNA-seq data and performs survival analysis with an extended Cox proportional hazards model. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results